UBQLN4 and cancer: GSEA indicated that the NES of the Wnt/β-catenin signaling pathway was 2.45 and the false discovery rate (FDR) q value <0.001, indicating that UBQLN4 is likely to exert its cancer-promoting effect via activating the Wnt/β-catenin signaling pathway.